About Therative

Management Team

Peter "Scotch" Scocimara, CEO
Luiz B. Da Silva, Ph.D., CTO

Board Members
Peter Scocimara, CEO
George Choi, President & CEO, Pavad Medical
Charles Moldow, General Partner, Foundation Capital
Mark Foley, Partner, RWI Ventures
Dr. Wally Buch, MD, Band of Angels

Management Team

Peter "Scotch" Scocimara, CEO

Scotch is the CEO and a founder of Therative. Prior to founding Therative, Scotch was the VP of Sales and Marketing for LiveOps, the leader in telemarketing services for TV marketing and infomercial programs. At LiveOps, Scotch grew revenue by 64% in 2004 and put the company on track for 67% growth in 2005.

From 2002 to 2004, Scotch was the VP of Customer Success at WebEx, the largest service as software provider. As a senior executive of the company, Scotch led the customer management and technical support teams; network and server operations and sales and marketing for the Corporate Business Unit. Scotch managed the growth in operations as the company grew from $81 million in revenue in 2001 to $189 million in 2003, and from $27 million in operating losses to $43 million in operating profit. Scotch was one of the senior executives who led the transition from software focused startup to service focused enterprise.

Prior to WebEx, Scotch was an EVP of Excite@Home where he built and managed the international operations of the combined entity and the start-up of three joint venture companies on three continents. Before joining @Home, Scotch developed and negotiated several joint ventures in Europe for Cummins Engine Company, a Fortune 200 manufacturer, and was an associate with the merchant banking group of Chase where he structured and executed leveraged transactions and private equity investments. A native of Switzerland, Scotch earned a bachelor's degree from Brown University and an MBA from Harvard University.

BACK TO TOP

Luiz B. Da Silva, Ph.D., CTO

Dr. Da Silva is one of the co-founders of Therative and serves as the Chief Technology Officer. He has been involved in medical device research and development in industry, university and national laboratories for over 8 years. Since leaving Lawrence Livermore National Laboratory (LLNL) in 2001, Dr. Da Silva has founded and served as CTO of DermaHealth Systems a plastic surgery device company, and ImagiNail Corporation a consumer product company. In addition, from 2001 to 2003, Dr. Da Silva served as the CTO and consultant of BioLuminate, Inc. a medical device company developing a cancer diagnostic system. While at LLNL, from 1998 to 2001, Dr. Da Silva served as the associate program leader for the medical technology program. Dr. Da Silva has worked as a consultant to several medical companies including Johnson & Johnson, Guidant, Boston Scientific, and Cyclotec Medical.

Dr. Da Silva received a Ph.D. in physics from the University of British Columbia in 1988. Dr. Da Silva is internationally recognized for his research and is a fellow of the American Physical Society and the Optical Society of America. He is currently on the scientific advisory board of the University of California, Davis National Science Foundation Center for Biophotonics Science and Technology. He has over 200 publications and 40 patents, and his research has earned him awards from the American Physical Society, the Institute of Electrical and Electronics Engineers (IEEE), R&D 100 and the Department of Energy.

BACK TO TOP

 

Board Members

Peter Scocimara, CEO

George Choi, President & CEO, Pavad Medical

George is the President & CEO of Pavad Medical, Inc., a medical device startup company developing therapeutic technologies within the field of Obstructive Sleep Apnea, since 2005. In addition to Pavad, he has been active in starting up other medical device companies based on novel technologies. His name can be found on several patents associated with these technologies in the U.S. and abroad, and he serves on the board of several of these companies.

Prior to Pavad, George was a Managing Member at MedVenture Associates, where he focused on raising capital and investing primarily in the life sciences sector, with an emphasis on early stage medical devices. Prior to joining MedVenture Associates, George was a corporate securities attorney with Wilson, Sonsini, Goodrich & Rosati, a Palo Alto law firm specializing in representation of start-up companies, working with private and public corporations in the biomedical and medical devices industry.

George received his B.S. degree in Electrical Engineering and Computer Science with a minor emphasis on Economics from the University of California, Berkeley and his J.D. degree from the University of California, Los Angeles School of Law.

BACK TO TOP

Charles Moldow, General Partner, Foundation Capital

Charles joined Foundation Capital on the heels of successfully building two companies from early start-up through greater than $100 million in sales. Charles' experience spans general management, sales, marketing, product management and business development at TellMe Networks, @Home Network (where he was a member of the founding team) and Matchlogic, an interactive advertising company.

Charles' entrepreneurial penchant dates back to 1989 when he co-founded two businesses. The first, OnTime Guide, established itself as the leading source of travel information for business executives, replacing the OAG Pocket Flight Guide as the must have resource for frequent business travelers. The second, PrimeTime Partners, attempted to establish a new category of self liquidating promotions on behalf of advertisers and direct marketers. Prior to the start-up ventures, Charles spent three years in the Mergers and Acquisitions practice at Merrill Lynch.

Charles holds a BS degree from the Wharton School at the University of Pennsylvania and received his MBA from Harvard University.

BACK TO TOP

Mark Foley, Partner, RWI Ventures

Since joining RWI Ventures, Mark has led RWI's investments in Chakshu, BaroSense and Therative, where he serves on the Board of all three companies. Prior to RWI Ventures, he spent 17 years in senior operating roles at both large and small start-up medical device companies, most recently founding and serving as CEO of cardiac device maker, Ventrica, which was acquired by Medtronic in 2004. Before Ventrica, Mark worked for leading device companies Perclose (acquired by Abbott), Guidant, DVI (acquired by Eli Lilly) and US Surgical Corporation (acquired by Tyco).

Because of the breadth of his operating experience, Mark has an intimate understanding of all aspects of what it takes to make a start-up company successful, as well as an extensive rolodex and strong personal relationships with many key influencers in the Bay Area and medical field. Mark received his B.A. from the University of Notre Dame.

BACK TO TOP

Dr. Wally Buch, MD, Band of Angels

Dr. Wally Buch, MD, has been an angel investor in many successful startup companies, including Neoforma (NEOF). He received his MD from Hahnemann University in Philadelphia, Pennsylvania, and completed his internship and residency in General and Cardiovascular Surgery at Stanford University Hospital. He had a successful private practice in Cardiovascular and Thoracic Surgery at both Stanford University Hospital in Palo Alto and Sequoia Hospital in Redwood City for more than 25 years. He is a Diplomate of the American Board of Surgery and the American Board of Thoracic Surgery. Currently Wally is a Venture Partner at MedVentures, and a Director of 3 early stage companies, including Therative.

BACK TO TOP